Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Valsartan 160mg; ; ;
Novartis New Zealand Ltd
Valsartan 160 mg
160 mg
Film coated tablet
Active: Valsartan 160mg Excipient: Colloidal silicon dioxide Crospovidone Hypromellose Iron oxide black Iron oxide red Iron oxide yellow Macrogol 8000 Magnesium stearate Microcrystalline cellulose Titanium dioxide
Blister pack, PVC/PVDC with Aluminium foil, 14 tablets
Prescription
Prescription
Novartis Pharma Schweizerhalle AG
Treatment of hypertension in adults and in children and adolescents 6-18 years of age.
Package - Contents - Shelf Life: Blister pack, PVC/PVDC with Aluminium foil - 14 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PA/Al/PVC foil with aluminium foil backing - 28 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PVDC with Aluminium foil - 28 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PVDC with Aluminium foil - 56 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/PVDC with Aluminium foil - 98 tablets - 36 months from date of manufacture stored at or below 30°C
2000-09-08